Kanes Stephen 4
4 · Sage Therapeutics, Inc. · Filed Sep 5, 2019
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-09-04$0.45/sh+6,000$2,700→ 8,292 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-09-04−6,000→ 86,100 totalExercise: $0.45Exp: 2023-07-23→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 18, 2017.